HomeProductsBioactive CompoundsProtein Kinase Targetsc-Met/HGFRMerestinib
Chemical structure of CAS 1206799-15-6

Merestinib

CAS No.1206799-15-6
MDL No.MFCD23160048
MFC30H22F2N6O3
MW552.50
InChI KeyQHADVLVFMKEIIP-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1206799-15-6
Product NameMerestinib

Biological Targets

MET

Associated Conditions

cutaneous melanoma·biliary tract cancer·Mantle cell lymphoma·non-small cell lung carcinoma·cancer·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Immunology • Vol. 160, Issue 1 • 2020
PMID: 32020584PMC: PMC7160657DOI: 10.1111/imm.13175

TAM receptor tyrosine kinases as emerging targets of innate immune checkpoint blockade for cancer therapy.

Immunological reviews • Vol. 276, Issue 1 • 2017
PMID: 28258690PMC: PMC5381815DOI: 10.1111/imr.12522

Interferon-γ regulates cellular metabolism and mRNA translation to potentiate macrophage activation.

Nature immunology • Vol. 16, Issue 8 • 2015
PMID: 26147685PMC: PMC4509841DOI: 10.1038/ni.3205

Inhibition of ron kinase blocks conversion of micrometastases to overt metastases by boosting antitumor immunity.

Cancer discovery • Vol. 3, Issue 7 • 2013
PMID: 23612011PMC: PMC3710539DOI: 10.1158/2159-8290.CD-12-0480

Documentation

Similar Products